NOVARTIS AG (NVSEF)
Clinical trial NCT07174063 updates: 1. completion date: 2027-06-18 → 2027-01-29 2. primary completion date: 2027-06-18 → 2027-01-29
Clinical trial NCT07174063 updates: 1. completion date: 2027-06-18 → 2027-01-29 2. primary completion date: 2027-06-18 → 2027-01-29
📉 **NEGATIVE** • Medium confidence analysis (73%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (18%) **Content type:** Clinical